TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Thursday reported third-quarter earnings of $1.01 billion.
On a per-share basis, the Tarrytown, New York-based company said it had net income of $8.89. Earnings, adjusted for one-time gains and costs, came to $11.59 per share.
The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $10.80 per share.
The biopharmaceutical company posted revenue of $3.36 billion in the period, also topping Street forecasts. Eight analysts surveyed by Zacks expected $3.24 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGN